14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:RXII
Delisted

RXI Pharmaceuticals Corporation Fund Price (Quote)

$0.82
+0 (+0%)
At Close: Dec 08, 2023

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 8th Dec 2023 RXII stock ended at $0.82. During the day the stock fluctuated 0% from a day low at $0.82 to a day high of $0.82.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical RXI Pharmaceuticals Corporation prices

Date Open High Low Close Volume
Feb 04, 2016 $28.00 $33.00 $28.00 $30.00 1 605
Feb 03, 2016 $31.00 $31.00 $28.00 $28.00 1 631
Feb 02, 2016 $29.00 $30.00 $28.00 $29.00 1 351
Feb 01, 2016 $29.00 $31.00 $27.00 $30.00 2 102
Jan 29, 2016 $29.00 $31.00 $27.00 $29.00 1 462
Jan 28, 2016 $30.00 $31.00 $29.00 $29.00 1 260
Jan 27, 2016 $29.00 $31.00 $29.00 $30.00 2 930
Jan 26, 2016 $33.00 $33.00 $29.00 $30.00 1 804
Jan 25, 2016 $32.00 $33.00 $30.00 $31.00 706
Jan 22, 2016 $30.00 $35.00 $30.00 $30.00 1 535
Jan 21, 2016 $29.00 $33.00 $28.00 $32.00 3 291
Jan 20, 2016 $27.00 $29.00 $27.00 $29.00 4 387
Jan 19, 2016 $28.00 $30.00 $28.00 $28.00 1 462
Jan 15, 2016 $28.00 $29.00 $27.00 $28.00 2 883
Jan 14, 2016 $28.00 $30.00 $27.00 $30.00 6 021
Jan 13, 2016 $32.00 $33.00 $27.00 $28.00 10 798
Jan 12, 2016 $32.00 $34.00 $32.00 $32.00 3 389
Jan 11, 2016 $38.00 $39.00 $30.00 $32.00 12 229
Jan 08, 2016 $38.00 $39.00 $36.00 $37.00 5 833
Jan 07, 2016 $37.00 $39.00 $36.00 $37.00 7 885
Jan 06, 2016 $39.00 $40.00 $37.00 $37.00 4 214
Jan 05, 2016 $39.00 $39.00 $37.00 $38.00 3 186
Click to get the best stock tips daily for free!

About RXI Pharmaceuticals Corporation

RXi Pharmaceuticals Corporation, a clinical-stage RNAi company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. The company develops therapies based on siRNA technology and immunotherapy agents. Its clinical development programs include RXI-109, a self-delivering RNAi compound, which is in Phase IIa clinical trial that is used to prevent or reduce dermal scarring following surgery or trauma... RXII Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT